Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Aug 31, 2022
- Accession no.
- 0001447362-22-000145
- Filed
- Aug 31, 2022
- Trade date
- Aug 29-30, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 21 non-derivative transactions. Open-market sales total $306.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2022 | Common Stock | SSaleDisposed | −4,032 | $29.55F2 | −$119,145.6 | 312,500 | Direct | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −1,978 | $29.55F2 | −$58,449.9 | 140,671 | Indirect | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −1,865 | $29.55F2 | −$55,110.75 | 128,430 | Indirect | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −396 | $29.55F2 | −$11,701.8 | 28,566 | Indirect | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −396 | $29.55F2 | −$11,701.8 | 28,564 | Indirect | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −396 | $29.55F2 | −$11,701.8 | 28,564 | Indirect | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −395 | $29.55F2 | −$11,672.25 | 28,563 | Indirect | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −86 | $30.15F9 | −$2,592.9 | 312,414 | Direct | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −42 | $30.15F9 | −$1,266.3 | 140,629 | Indirect | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −40 | $30.15F9 | −$1,206 | 128,390 | Indirect | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −8 | $30.15F9 | −$241.2 | 28,558 | Indirect | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −8 | $30.15F9 | −$241.2 | 28,556 | Indirect | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −8 | $30.15F9 | −$241.2 | 28,556 | Indirect | |
| Aug 29, 2022 | Common Stock | SSaleDisposed | −9 | $30.15F9 | −$271.35 | 28,554 | Indirect | |
| Aug 30, 2022 | Common Stock | SSaleDisposed | −300 | $29.42F10 | −$8,826 | 312,114 | Direct | |
| Aug 30, 2022 | Common Stock | SSaleDisposed | −147 | $29.42F10 | −$4,324.74 | 140,482 | Indirect | |
| Aug 30, 2022 | Common Stock | SSaleDisposed | −137 | $29.42F10 | −$4,030.54 | 128,253 | Indirect | |
| Aug 30, 2022 | Common Stock | SSaleDisposed | −29 | $29.42F10 | −$853.18 | 28,529 | Indirect | |
| Aug 30, 2022 | Common Stock | SSaleDisposed | −29 | $29.42F10 | −$853.18 | 28,527 | Indirect | |
| Aug 30, 2022 | Common Stock | SSaleDisposed | −29 | $29.42F10 | −$853.18 | 28,527 | Indirect | |
| Aug 30, 2022 | Common Stock | SSaleDisposed | −29 | $29.42F10 | −$853.18 | 28,525 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $29.13 to $30.12, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $30.14 to $30.15, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $29.32 to $29.57, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.